Opinions and Legal Insights

Latham & Watkins Advises Guardant Health, Inc. in US$1 Billion Convertible Senior Notes Offering

Guardant Health, Inc., a leading precision oncology company, has announced the pricing of its offering of US$1 billion aggregate principal amount of 0% convertible senior notes due 2027 in a […]

The post Latham & Watkins Advises Guardant Health, Inc. in US$1 Billion Convertible Senior Notes Offering appeared first on Legal Desire.